Home Healthcare Biotechnology Monoclonal Antibodies Market

Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Type (Human, Humanized, Chimeric, Murine), By Application (Oncology, Autoimmune Diseases, Hematologic diseases, Neurological Diseases, Infectious Diseases, Dermatology, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Monoclonal Antibodies Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Human
    2. Humanized
    3. Chimeric
    4. Murine
  2. Monoclonal Antibodies Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune Diseases
    3. Hematologic diseases
    4. Neurological Diseases
    5. Infectious Diseases
    6. Dermatology
    7. Others
  3. Monoclonal Antibodies Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Others
  4. Regional Monoclonal Antibodies Market
    1. North America
      1. North America Monoclonal Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
      2. North America Monoclonal Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Hematologic diseases
        4. Neurological Diseases
        5. Infectious Diseases
        6. Dermatology
        7. Others
      3. North America Monoclonal Antibodies Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Others
      4. U.S.
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      5. Canada
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
    2. Europe
      1. Europe Monoclonal Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
      2. Europe Monoclonal Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Hematologic diseases
        4. Neurological Diseases
        5. Infectious Diseases
        6. Dermatology
        7. Others
      3. Europe Monoclonal Antibodies Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Others
      4. U.K.
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      5. Germany
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      6. France
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      7. Spain
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      8. Italy
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      9. Russia
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      10. Nordic
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      11. Benelux
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      12. Rest of Europe
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
    3. APAC
      1. APAC Monoclonal Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
      2. APAC Monoclonal Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Hematologic diseases
        4. Neurological Diseases
        5. Infectious Diseases
        6. Dermatology
        7. Others
      3. APAC Monoclonal Antibodies Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Others
      4. China
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      5. Korea
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      6. Japan
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      7. India
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      8. Australia
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      9. Taiwan
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      10. South East Asia
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      11. Rest of Asia-Pacific
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Monoclonal Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
      2. Middle East and Africa Monoclonal Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Hematologic diseases
        4. Neurological Diseases
        5. Infectious Diseases
        6. Dermatology
        7. Others
      3. Middle East and Africa Monoclonal Antibodies Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Others
      4. UAE
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      5. Turkey
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      6. Saudi Arabia
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      7. South Africa
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      8. Egypt
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      9. Nigeria
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      10. Rest of MEA
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
    5. LATAM
      1. LATAM Monoclonal Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
      2. LATAM Monoclonal Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Hematologic diseases
        4. Neurological Diseases
        5. Infectious Diseases
        6. Dermatology
        7. Others
      3. LATAM Monoclonal Antibodies Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Others
      4. Brazil
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      5. Mexico
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      6. Argentina
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      7. Chile
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      8. Colombia
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
      9. Rest of LATAM
        1. Human
        2. Humanized
        3. Chimeric
        4. Murine
        5. Oncology
        6. Autoimmune Diseases
        7. Hematologic diseases
        8. Neurological Diseases
        9. Infectious Diseases
        10. Dermatology
        11. Others
        12. Hospital Pharmacies
        13. Drug Stores & Retail Pharmacies
        14. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.